Stock listing
Boundless Bio, Inc.
Selected listing: BOLD · NASDAQ · USD · US
Boundless Bio, Inc. (NASDAQ:BOLD), Health Technology. Latest release Jun 23, 2026: Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million…
- Ticker
- NASDAQ:BOLD
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Boundless Bio, Inc.
The company is focused on developing innovative therapies for cancer treatment. As a publicly traded entity, it is listed on the American stock market, providing investors with opportunities to engage with its growth and developments.
Latest news from Boundless Bio, Inc.
Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement
June 22, 2026
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
May 8, 2026
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
April 17, 2026
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
March 16, 2026
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
March 8, 2026